Carrolee Barlow

Insider Reports History

Entity
Individual
Location
C/O Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD
Signature
/s/ Timothy C. Dec, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carrolee Barlow:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SUPERNUS PHARMACEUTICALS, INC. Director Common Stock 17.2K $500K $29.06 Feb 23, 2024 Direct
SUPERNUS PHARMACEUTICALS, INC. Director Restricted Stock Units 0 $0 $29.06 Feb 23, 2024 Direct
SUPERNUS PHARMACEUTICALS, INC. Director Director Stock Option (Right to Buy) 8.25K Feb 22, 2024 Direct

Insider Reports Filed by Carrolee Barlow

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 23, 2024 2 $0 4 Feb 27, 2024 Director
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 22, 2024 2 $0 4 Feb 26, 2024 Director
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 23, 2023 2 $0 4 Feb 27, 2023 Director
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 22, 2023 2 $0 4 Feb 24, 2023 Director
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 22, 2022 2 $0 4 Feb 24, 2022 Director
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 19, 2022 2 $0 4 Feb 23, 2022 Director